Socioeconomic Inequalities in Disability-free Life Expectancy in Older People from England and the United States: A Cross-national Population-Based Study by Martin, Hyde
906
Journals of Gerontology: Medical Sciences
cite as: J Gerontol A Biol Sci Med Sci, 2020, Vol. 75, No. 5, 906–913
doi:10.1093/gerona/glz266
Advance Access publication January 15, 2020
© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), 
which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Research Article
Socioeconomic Inequalities in Disability-free Life 
Expectancy in Older People from England and the United 
States: A Cross-national Population-Based Study
Paola Zaninotto, PhD,1,*,  George  David Batty, PhD,1,  Sari Stenholm, PhD,2,   
Ichiro Kawachi, PhD,3 Martin Hyde, PhD,4 Marcel Goldberg, PhD,5,6,  Hugo Westerlund, 
PhD,7 Jussi Vahtera, MD,2 and Jenny Head, MSc1
1Department of Epidemiology and Public Health, University College London, UK. 2Department of Public Health, University of Turku and 
Turku University Hospital, Finland. 3Department of Social and Behavioral Sciences, Harvard University, Boston, Massachusetts. 4Centre 
for Innovative Ageing, College of Human and Health Sciences, Swansea University, UK. 5Inserm, Population-based Epidemiologic Cohorts 
Unit-UMS 011, Villejuif, France. 6Inserm, Aging and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France. 
7Stress Research Institute, Stockholm University, Sweden.
*Address correspondence to: Paola Zaninotto, PhD, Department of Epidemiology and Public Health, University College London, 1–19 Torrington 
Place, London, WC1E 7HB, UK. E-mail: p.zaninotto@ucl.ac.uk
Received: August 13, 2019; Editorial Decision Date: November 6, 2019
Decision Editor: Anne Newman, MD, MPH
Abstract
Background: We examined socioeconomic inequalities in disability-free life expectancy in older men and women from England and the United 
States and explored whether people in England can expect to live longer and healthier lives than those in the United States.
Methods: We used harmonized data from the Gateway to Global Aging Data on 14,803 individuals aged 50+ from the U.S. Health and 
Retirement Study (HRS) and 10,754 from the English Longitudinal Study of Ageing (ELSA). Disability was measured in terms of impaired 
activities and instrumental activities of daily living. We used discrete-time multistate life table models to estimate total life expectancy and life 
expectancy free of disability.
Results: Socioeconomic inequalities in disability-free life expectancy were of a similar magnitude (in absolute terms) in England and the United 
States. The socioeconomic disadvantage in disability-free life expectancy was largest for wealth, in both countries: people in the poorest group 
could expect to live seven to nine fewer years without disability than those in the richest group at the age of 50.
Conclusions: Inequalities in healthy life expectancy exist in both countries and are of similar magnitude. In both countries, efforts in reducing 
health inequalities should target people from disadvantaged socioeconomic groups.
Keywords:  Disability, Healthy life expectancy, Socioeconomic status, Cross-national
Life expectancy has increased dramatically in the United States 
and United Kingdom over the last century, however, new evidence 
emerged showing that in more recent years life expectancy at birth 
has been decreasing in the United States (1) and leveling off in the 
United Kingdom (2). Simultaneously, increases in the prevalence 
of disability and chronic conditions among older adults have been 
reported in the United States (3), England (4), and globally (5), 
bringing financial challenges for governments and health care sys-
tems worldwide.
While life expectancy is a useful indicator of health, it is be-
coming increasingly recognized that quantification of the quality of 
remaining years of life is also crucial (6). Health expectancy gives an 
estimate of the number of years of life spent in favorable states of 
health or without disability. Health expectancy measures have value 
for monitoring time trends and inequalities in population health be-
cause they combine data on both mortality and morbidity or dis-
ability (7). While health differences between older Americans and 
older English people are well documented (8–11), direct comparisons 
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between these two countries in healthy life expectancy at older ages 
are less documented.
It is now well established that in the United States and England, 
there are striking socioeconomic inequalities, in both general health 
and life expectancy (8,9,12–18), with apparent socioeconomic grad-
ations, rather than differences only being seen between rich and poor. 
While these studies show differences between countries in health and 
socioeconomic differences within each country in health expectancy, 
differences between these two countries in socioeconomic inequal-
ities in health expectancy have not yet been investigated. Health care 
coverage in England is publicly funded, whereas in the United States, 
it is provided through private health insurance (for many working-
age adults) and through publicly funded health insurance for the 
poor (Medicaid) as well as those aged 65 years and older. With the 
introduction of the Affordable Care Act, the number of uninsured 
individuals in the United States declined (19), however, economically 
disadvantaged individuals and those in worse health still have more 
difficulty accessing health care. Lack of health insurance among 
those aged below 65 years does not only affect prevention and early 
diagnosis, but also access to appropriate medical intervention when 
serious illness strikes and the ability to pay for other needs, such 
as adequate housing and food. Furthermore, since access to health 
care is not the only explanation for inequalities in health (20), cross-
national comparisons of health expectancy can also help evaluating 
strategies adopted in different countries to help reducing health in-
equalities. Other possible explanations for greater health inequalities 
in the United States compared to England (10) might relate to a more 
generous welfare state system in England compared to the United 
States, including unemployment compensation, sick pay, housing 
policies, and social retirement benefits. These contextual factors can 
in turn provide better psychosocial health and reduced stress, es-
pecially among socioeconomically disadvantaged groups. It is pos-
sible that older Americans are exposed to more psychosocial distress, 
which has been shown to increase the risk of chronic conditions and 
early mortality (21).
The health indicators that have commonly been used to compute 
health expectancy include, among others, self-rated health (referred 
to as “healthy life expectancy”), activities of daily living (ADL) 
and/or instrumental activities of daily living (IADL) (referred to as 
“disability-free life expectancy”), and chronic morbidity (referred to 
as “chronic disease-free or morbidity-free life expectancy”) (17,22–
24). However, self-rated health is based on subjective health status 
and identical questions may not mean the same to people across 
different cultures. Disability-free life expectancy is one of the most 
widely accepted measure of health expectancy (22) and has been re-
commended in cross-country comparative studies (17) because it is 
less sensitive to cultural factors.
Lack of harmonization of both health and socioeconomic meas-
ures is often one of the main obstacles for comparing health ex-
pectancies between countries (17,22). However, the Health and 
Retirement Study (HRS) in the United States (25) and the English 
Longitudinal Study of Ageing (ELSA) (26,27) were expressly de-
signed to be comparable, hence providing a unique opportunity for 
cross-national comparisons of inequalities in health expectancy. In 
exploring inequalities in health in later life, the use of a range of 
socioeconomic indicators has been recommended (28), however, 
most studies of inequalities in health expectancy have focused on 
education and occupational social class (22). Given the link between 
lifetime socioeconomic status and health (29,30), the use of several 
measures of socioeconomic position that can capture different stages 
of life may yield a better understanding of how socioeconomic status 
relates to late life health and longevity. In particular, wealth is con-
sidered a useful indicator of the long-term socioeconomic status of 
older people since it captures both past and present circumstances 
(28,31,32).
Although it is well established that individuals in lower 
socioeconomic groups in England have better health that people in 
higher socioeconomic groups in the United States (8,10), the extent 
to which these socioeconomic differences between the two countries 
extend to healthy life expectancy is not known. The aim of this study 
was to explore whether the health disadvantage of older Americans 
extends to healthy life expectancy. Furthermore, we explored the 
extent to which inequalities in healthy life expectancy within each 
country differed according to different measures of socioeconomic 
status. We used socioeconomic indicators selected from different 
stages of life namely, education, wealth, and social class.
Methods
Data
We used data from two prospective cohort studies of ageing: ELSA 
and HRS. Established 10 years after HRS, ELSA was designed to 
be comparable in terms of population sampling, periodicity, and 
content (including the specific wording of questions) (33,34). The 
two studies have been described in detail elsewhere (25,26). Briefly, 
HRS (25) is a nationally representative biennial longitudinal survey 
of people aged 51  years and older that began in 1992 and cur-
rently includes more than 37,000 individuals. Since 1992 HRS has 
grown to represent all Americans aged 50  years and older (25). 
The sample selection was based on a multistage area probability 
design involving geographical stratification and clustering. Baseline 
data collection is through face-to-face interviews and follow-up 
interviews rotate between face-to-face and telephone administra-
tion (for those aged less than 80  years). National representation 
of this population is maintained over time using a steady state de-
sign which adds a new cohort of persons entering their 50’s every 
6 years.
ELSA (26,27), is also an open-access, nationally representa-
tive, biennial longitudinal survey of those aged 50 years and older 
living in private households in England that began in 2002/2003. 
The sample was drawn from participants in the Health Survey 
for England (HSE), an annual cross-sectional survey that is de-
signed to monitor the health of the general population (35). For 
the first wave (2002/2003), participants were recruited from the 
HSE by using a two-stage stratified random sampling process. Data 
were also collected through face-to-face interviews at each wave. 
Comparisons of the sociodemographic characteristics of partici-
pants against results from the 2011 national census indicate that 
the sample was broadly representative of the English population 
(26). Informed consent was obtained from all individual partici-
pants included in the study.
To maximize comparability, we used harmonized data files, from 
2002/2003 to 2012/2013, available from The Gateway to Global 
Aging Data (g2aging.org) which is a data and information platform 
developed to facilitate cross-country analyses. The data files pro-
vided a set of harmonized or identically defined variables.
In both cohorts, we included people aged 50 years or older with 
valid data on health and socioeconomic status, resulting in analytical 
samples of 10,754 (out of the 11,391 ELSA members in 2002/2003) 
and 14,803 (out of the 17,758 HRS members in 2002 aged 50 years 
and older) (refreshment samples added after 2002 are excluded from 
these analyses).
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Socioeconomic Indicators
In both countries, total household wealth (10) (sum of net finan-
cial wealth and net housing wealth less all debts) was divided into 
three groups (ie, each containing 33% of the sample). Educational 
attainment (10) was defined as: low (less than high school), medium 
(high school graduate and some college), and high (college or more). 
Based on the Standard Occupational Classification 2000, we defined 
occupational social class (36) as high (managers, professionals, asso-
ciate professionals, or technical occupations), intermediate (admin-
istrative and secretarial, personal services, sales), and low (routine, 
manual, elementary occupations), with those who never worked or 
long-term unemployed being excluded. All variables were measured 
in 2002 (for some people, social class was measured before 2002; 
therefore, information from earlier waves was used).
Outcome Measures
We measured health expectancy using the presence of disability. 
At each wave in both studies, all participants were asked whether 
they had difficulties in performing activities of daily living (ADL) 
(eg, dressing, walk across a room, bathing or showering, eating, 
getting in/out of bed, using the toilet) and instrumental activities of 
daily living (IADL) (eg, using a map, preparing a hot meal, shopping 
for groceries, making phone calls, taking medications, managing 
money). Responses were summed and categorized as no disability 
(0 or 1 ADL/IADL) and disability (2+ ADL/IADL). The cutoff of 2 
or more ADL or IADL was chosen based on the average number of 
ADL or IADL limitations reported by people (in ELSA) who at base-
line were in receipt of health or disability benefits. Health expectancy 
based on disability is named here as disability-free life expectancy.
Mortality up to March 2013 was ascertained from linked register 
data for ELSA and through linkages to the National Death Index 
and reports from survivors for HRS.
Statistical Analyses
Total length of time in study was 10  years (from 2002/2003 to 
2012/2013, average follow-up 6  years); by the end of follow-up 
period, 4,275 deaths occurred in the U.S. sample and 2,470 in the 
English sample.
We used discrete-multistate life table models (17,37,38) suitable 
for longitudinal data to estimate health expectancy for the ages of 
50–100. We defined the following three health states: healthy, un-
healthy, and dead. There were four possible transitions between the 
health states, namely: healthy to unhealthy (onset), unhealthy to 
healthy (recovery), healthy to dead, unhealthy to dead.
To estimate multistate life table functions, we used the Stochastic 
Population Analysis for Complex Events (SPACE) program (37) in 
SAS 9.2. There are two main components to this program: the data 
component, which prepares the input datasets and the statistical com-
ponent, in which transition probabilities and the multistate life table 
functions and their variances are estimated. Specifically, during the 
data component, age-specific transition probabilities for all possible 
transitions are estimated from the data using multinomial logistic re-
gression conditional on age and sex (included as covariates in the 
model). Health expectancies for the age of 50–100 are then calculated 
based on these estimated transition probabilities using a stochastic 
(micro-simulation) approach. By using micro-simulation, it is pos-
sible to simulate the life paths of the members of the population in 
order to derive several summary statistics of the population dynamics. 
For each study separately, the program generated individual trajec-
tories for a simulated cohort of 100,000 persons with distributions of 
covariates at the starting point based on the observed study-specific 
prevalence by 5-year age group, sex, and socioeconomic indicators. 
Variability measures for these multistate life table estimates (vari-
ances, standard errors, and corresponding 95% confidence intervals) 
are computed using a bootstrap method with 500 replicates for the 
whole analysis process (multinomial analysis and simulation steps). 
Analyses were weighted by nonresponse weights.
Sensitivity Analyses
To assess the influence of race on the results, we computed estimates 
of healthy life expectancy by socioeconomic indicators in white 
people only for both countries.
To further assess whether our results were driven by the dif-
ferent distribution of the samples for social class and education, 
we computed the relative index of inequalities scores for these 
socioeconomic indicators. The scores were defined as the cumulative 
rank of each social class or education group (39), based on propor-
tions in each group (which is equal to the proportion of participants 
in higher social class groups plus one half of the proportion of parti-
cipants within their own social class group). This takes into account 
of the relative size of groups in the two countries. The relative index 
of inequalities score was entered as a linear term in the model, and 
then the healthy life expectancy was estimated for relative index of 
inequalities scores of 0.85 (low), 0.5 (median), and 0.15 (high).
Results
Baseline characteristics for men and women in each country are 
presented in Table 1. Men and women in England were slightly 
younger and more than 97% were of white origins compared to 
88% in the United States. In the United States, the majority of the 
sample reported middle social class and medium education, whereas 
in England, the majority of men and women reported being in a 
low occupational grade and low education category. The prevalence 
of disability was 13% in English men and 16% in women slightly 
higher than in the United States (10% men and 13% women, p-value 
for the country difference in each sex <.001).
Total life expectancy and disability-free life expectancy estimates 
by gender at the age of 50, 60, 70, and 80 in the United States and 
England are reported in Table 2. Estimates of total life expectancy 
and disability-free life expectancy (not adjusted) at all ages were very 
similar in women in both countries (life expectancy in women was 
34.8 years in England and 34.7 in the United States and disability-
free life expectancy 28.5 years in England and 28.6 in  the United 
States). For men, estimates of total life expectancy at the age of 50 
and 60 were very similar in the two countries, for example, men aged 
50 years in England could expect to live an additional 31.3 years and 
men in the United States 31.5, of these, 26.9 and 27.2 years, respect-
ively, will be spent without disability. At the age of 70 and 80 years, 
older American men could expect to live up to 1 year longer than 
older English men. Estimates of average number of years expected 
to live without disability, at the age of 60, 70, and 80, were slightly 
higher in men in the United States than men in England. Women in 
England and the United States could expect to live longer than men, 
however, disability-free life expectancy at the age of 80 was the same 
in men and women in both countries.
In Figure 1, we show estimates of disability-free life expectancy 
for men and women at the age of 50, 60, 70, and 80 according to 
social class. Socioeconomic differentials in disability-free life expect-
ancy were apparent in both countries at each age and showed similar 
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levels of magnitude: at the age of 50 men and women in the lowest 
social class group compared to those in the highest group could ex-
pect to live 5 fewer years (absolute differences) free from disability in 
England and the United States. In both countries and both genders, 
the absolute difference in disability-free life expectancy between 
the lowest and highest social class decreased with age. Within each 
socioeconomic group and at all ages, disability-free life expectancy 
estimates were very similar in the two countries.
In Figure 2, we show estimates of disability-free life expectancy for 
men and women at the age of 50, 60, 70, and 80 according to wealth. In 
both countries, at the age of 50, men and women in the richest wealth 
groups could expect to live an additional 8–9 years free from disability 
compared to those in the poorest groups (31.0 and 31.1  years for 
wealthiest men in England and the United States, respectively, vs 22.8 
and 22.2 years in men in England and the United States in poorest 
wealth groups; 33.1 and 32.8 years for wealthiest women in England 
the United States, respectively, vs 24.6 and 24.0 years in women in 
England and the United States in poorest wealth groups).
Estimated years expected to live without disability decreased at 
the age of 60, 70, and 80 in each wealth group, but the socioeconomic 
gradient remained and the absolute difference between richest and 
poorest was 7–8 years at the age of 60, 6–7 years at the age of 70 
and 3–5 years at the age of 80. Within each wealth group and at all 
ages, disability-free life expectancy estimates were very similar in the 
two countries.
The gradient in additional years of disability-free life expect-
ancy is less marked by education in England compared to the United 
States (Figure 3). At the age of 50, we observed an absolute differ-
ence of 5–6 years between those with low education and those with 
high education in England, whereas the difference was 9 years in the 
United States. At older ages, the difference between the most and 
least educated reduced, but remained significant. Within each edu-
cation group and at all ages, disability-free life expectancy estimates 
were very similar in the two countries.
Of the socioeconomic indicators, the absolute difference in 
disability-free life expectancy was largest for wealth in England and 
Table 2. Total Life Expectancy and Disability-free Life Expectancy by Age and Sex, England and the United States (2002–2013)
Total life expectancy
Men Women
England (ELSA) 
Years (95% CI)
United States (HRS) 
Years (95% CI)
England (ELSA) 
Years (95% CI)
United States (HRS) 
Years (95% CI)
Age 50 31.3 (30.7; 31.8) 31.5 (31.0; 31.9) 34.8 (34.2; 35.4) 34.7 (34.2; 35.2)
Age 60 22.2 (21.6; 22.6) 22.7 (22.3; 23.1) 25.5 (24.9; 26.0) 25.5 (25.0; 25.9)
Age 70 14.2 (13.8; 14.6) 15.0 (14.7; 15.3) 16.9 (16.5; 17.4) 17.4 (17.0; 17.7)
Age 80 8.1 (7.9; 8.5) 9.1 (8.8; 9.4) 10.3 (10.0; 10.6) 10.7 (10.4; 11.0)
Disability-free life expectancy
Age 50 26.9 (26.4; 27.4) 27.2 (26.7; 27.7) 28.5 (27.9; 29.0) 28.6 (28.0; 28.9)
Age 60 18.1 (17.6; 18.5) 18.8 (18.5; 19.1) 19.6 (19.1; 20.1) 19.5 (19.1; 19.9)
Age 70 10.8 (10.4; 11.2) 11.5 (11.2; 11.8) 11.6 (11.3; 12.1) 12.0 (11.7; 12.4)
Age 80 5.5 (5.2; 5.9) 6.2 (5.9; 6.4) 6.2 (5.9; 6.5) 6.2 (5.9; 6.6)
Note: CI = Confidence interval; ELSA = English Longitudinal Study of Ageing; HRS = Health and Retirement Study.
Table 1. Baseline Characteristics of Participants in ELSA and HRS, England and the United States (2002–2003)
Men Women
England (ELSA) United States (HRS) England (ELSA) United States (HRS)
Sample size 4,980 6,805 5,774 7,998
Mean age (SD) 64.3 (10.5) 66.6 (11.0) 65.7 (11.7) 66.5 (11.4)
Ethnicity % % % %
 White 96.7 88.2 98.1 86.3
Social class
  Low grade 52.4 28.2 31.1 11.7
  Middle grade 10.3 37.0 46.5 58.0
  High grade 37.3 34.8 22.4 30.3
Wealth
  Poorest 34.8 25.5 38.4 31.6
  Middle 33.0 34.2 33.1 34.5
  Richest 32.2 40.3 28.5 33.9
Education
  Low 48.9 26.6 56.0 22.8
  Medium 36.0 47.1 36.2 59.0
  High 15.1 26.3 7.8 18.2
Disabilitya
  No 87.4 90.0 84.2 86.6
  Yes 12.6 10.0 15.8 13.4
Note: ELSA = English Longitudinal Study of Ageing; HRS = Health and Retirement Study; SD = Standard deviation.
aTwo or more limitations with instrumental/activities of daily living.
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wealth and education in the United States, such that people in the 
most advantaged groups could expect to live  longer without dis-
ability than those in the most disadvantaged groups.
Results of the sensitivity analyses are presented in the 
Supplementary Material. Estimates of disability-free life expectancy 
for white people only by socioeconomic indicators (Supplementary 
Tables 1–3) were very similar to those obtained for the sample 
that included non-white ethnicities (Figures 1–3). A  few excep-
tions should be mentioned: the estimates by social class restricted 
to white people were slightly higher in low social class groups for 
men and women in the United States and the  absolute difference 
between higher and lower social class was slightly smaller than that 
found in the whole sample. The results by education among white 
people also showed some small differences: men and women in the 
United States at the age of 50 and 60 in low education groups had 
slightly higher disability-free estimates compared to results in Figure 
3. Furthermore, the absolute difference in disability-free life ex-
pectancy between the lowest and the highest education groups was 
1 year higher for men and women in England at the age of 50 and 
60 and 1 year lower for men and women in the United States at the 
age of 50 (and 80 for women only).
In Supplementary Tables 4 and 5 in the Supplementary Material, 
we report estimates of disability-free life expectancy according 
to the relative index of inequalities scores for social class and 
Figure 1. Disability-free life expectancy estimates according to social class 
and age, men and women in England and the United States (2002–2013).
Figure 2. Disability-free life expectancy estimates according to wealth and 
age, men and women in England and the United States (2002–2013).
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education. With a few exceptions, estimates are similar to those re-
ported in Figures 1 and 3, suggesting that overall the distribution 
of socioeconomic indicators within each country did not affect the 
results. A few differences should be reported: the absolute difference 
between the highest and lowest social class groups in England was 
1 year larger for men at the age of 50 and 60 and, for women at the 
age of 50 than the absolute difference reported in Figure 1, whereas 
in the United States, for men, the absolute difference was smaller 
by 1 year at the age of 60 and 80. For each education group, the 
difference between the United States and England in estimates of 
disability-free life expectancy at the age of 50 and 60 reduced when 
RII was employed. Furthermore, the absolute difference between the 
highest and lowest education groups in England was 1 year larger 
for men at the age of 50 and 60 and, for women at the age of 50, 
whereas in the United States the absolute difference was 1  year 
smaller at the age of 50 and 60 for men and at the age of 50 and 80 
for women.
Discussion
Using two large nationally representative samples of older individ-
uals from the United States and England followed from 2002 until 
2013 we showed, for the first time, that estimates of total life expect-
ancy and disability-free life expectancy among women in the United 
States and in England (from HRS and ELSA) are nearly the same, at 
the age of 50, 60, 70, and 80, respectively. Among men, we observed 
similar estimates of total life expectancy at the age of 50 and 60 and 
at the age of 50 for disability-free life expectancy. There was a small 
advantage of up to 1 year for older American men at the age of 70 
and 80 compared to older English men. Similarly, older men in the 
United States could expect to live approximately half a year longer 
without disability than men in England at the age of 60, 70, and 
80. However, this apparent advantaged was no longer present in the 
estimates of disability-free life expectancy by socioeconomic status.
Furthermore, we showed that within each country, there was a 
consistent advantage for people in high socioeconomic groups, par-
ticularly for wealth and education, so that they could expect to live a 
higher number of years without disability. We found that within each 
country, inequalities in disability-free life expectancy were of similar 
magnitude. The absolute differences in disability-free life expectancy 
by socioeconomic indicators decreased with age. A possible explan-
ation is mortality selection, which indicates that when mortality at 
younger ages is high, it affects frail people first; therefore, survivors 
at older ages are a selected group of healthier people (40). Another 
possible explanation is the “age-as-leveler” hypothesis indicating that 
health inequalities decrease at older ages (41).
Among the socioeconomic indicators considered, wealth gen-
erated the greatest disparities in disability-free life expectancy in 
England and the United States.
Given the novelty of our study, direct comparisons with previous 
studies is not possible. Nevertheless, our observation that wealth re-
vealed greatest disparities in disability-free life expectancy is in line 
with previous studies exploring socioeconomic inequalities in health 
(32,42). Wealth is a measure of lifetime economic advantage or dis-
advantage, reflecting both past and current circumstances because 
it comprises of assets from inheritance, lifelong income, as well as 
patterns in spending and saving. Higher wealth gives access to better 
housing, healthier life styles as well as better health services.
Our results of education and social class inequalities in disability-
free life expectancy within England and the United States are in ac-
cordance with those found in previous studies (12–15).
To the best of our knowledge, this is the first study to pro-
vide direct comparisons between older adults in England and the 
United States of socioeconomic inequalities in disability-free life 
expectancy. A  typical problem of comparisons of health expect-
ancies between countries is the lack of harmonization of health 
measures. Therefore, a major strength of our study is that it draws 
upon studies specifically designed to be comparable, hence pro-
viding high-quality harmonized data of multiple measurements of 
disability over time. Our method of estimating disability-free life 
expectancy used discrete multistate life table models applied to lon-
gitudinal data. The multistate life tables method has several advan-
tages: it is based on incidence measures representing current health 
Figure 3. Disability-free life expectancy estimates according to education and 
age, men and women in England and the United States (2002–2013).
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transitions; it allows movement in both directions between all sur-
viving health states; and it allows death rates to differ by health 
state therefore it takes into account the different mortality profiles 
by health status. In addition, we used a broad selection of indica-
tors of socioeconomic status from different stages of life. Thus, our 
study makes a unique contribution in understanding the levels of 
inequalities in health expectancies between England and the United 
States. Our results can be generalized to the English and American 
population of older individuals.
A possible limitation of our study might be related to the fact that 
participants in longitudinal studies tend to be healthier than those in 
the general population, thus mortality rates may not match those ob-
served nationally in the United States and England. If that is the case, 
it is possible that we have overestimated life expectancy and disability-
free life expectancy. To further explore this possibility, we compared 
our estimates of total life expectancy with national life tables (43,44), 
and found similar results for England and slightly higher estimates for 
the United States compared to life tables. Although we used harmon-
ized data, some differences between the countries in the distribution 
of education and social class were found. To further assess whether 
our results were driven by the different distribution of the samples 
for social class and education, we computed the relative index of in-
equalities scores for these socioeconomic indicators. We found that 
for education the difference in disability-free life expectancy estimates 
between the two countries reduced slightly; the absolute difference 
between the top and lowest education groups increased up to 1 year 
for England and decreased for the United States. Lastly, although both 
studies have been shown to be nationally representative (25,26,45), 
they might not totally reflect the diversity of their respective popu-
lations. In HRS, oversamples of Asians Americans have not been 
included; however, according to the U.S. Census 2000, only 2.6% per-
cent of all persons aged 65 years and over were Asians. In ELSA, the 
prevalence of non-white people is very small, however, comparisons 
of the sociodemographic characteristics of participants against results 
from the 2011 national census indicate that the sample was broadly 
representative of the English population (26). Furthermore, estimates 
of disability-free life expectancy by socioeconomic indicators among 
white people only were, as expected, slightly higher in both England 
and the United States and inequalities were up to 1  year larger in 
England and up to 1 year smaller in the United States. Overall, the 
conclusions remained the same.
Conclusions
Levels of disability-free life expectancy in the United States and in 
England (from HRS and ELSA) are approximately the same. We 
have shown that in England and the United States, despite living 
longer lives, not all the increased years of life are being spent in op-
timal health. Our findings have implications for policy makers inter-
ested in reducing health expectancy inequalities. Improving both 
the quality and the quantity of years that individuals are expected 
to live has implications for public expenditure on health, income, 
and long-term care need of older people as well as work partici-
pation in older ages. Furthermore, our results of similar levels of 
socioeconomic disadvantage in health expectancy in England and 
the United States suggest that in both countries greater efforts should 
be put into reducing health inequalities. As suggested by the Marmot 
review (18), such efforts should be placed into improving opportun-
ities across the social determinants of health: education, occupation, 
income, home, and community.
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